Avalon Pharmaceuticals is a next-generation genomics based company utilizing unique and proprietary methods to accelerate the discovery of small molecule drugs directly from genomics data. Through its comprehensive genomics approach, Avalon is able to pinpoint new drug targets and screen them in complex biological systems, facilitating the identification of small molecule lead compounds. Currently, Avalon is focusing its efforts on isolating new potential drug targets that play key roles in the malignant transformation of cancer cells, and coupling these targets with approaches for rapid identification of novel therapeutic compounds.
